Parameters | Description |
---|---|
Category of Drug | Atorvastatin is Lipid-Lowering Drug. Read more: Which are the popular Medicines prescribed for Heart Disorders? |
Structure | |
IUPAC Name | (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid |
Molecular details | Mol formula- C33H35FN2O5 Molecular weight- 558.6 g/mol |
Mechanism of Action | Atorvastatin competitively inhibits HMG-CoA reductase (3-hydroxy-2-methylglutaryl Coenzyme A) enzyme and prevents the conversion of HMGCoA to mevalonate. It also enhances the uptake of low-density lipoproteins (LDL) in the liver by upregulating the LDL receptors. It also elicits its action by reducing the very low-density lipoproteins- cholesterol, serum triglycerides, and intermediate-density lipoproteins. |
Indications | Atorvastatin is used for 1. Primary and secondary hypercholesterolemia 2. Prevention of cerebrovascular accidents 3. Primary prevention of coronary heart disease |
Well Known Pharmaceutical Brands | ATOCOR- DRL ATORLIP- CIPLA ATORVA- ZYDUS CADILA AZTOR- SUN LIPICURE- INTAS STATOR- ABBOTT STORVAS-SUN TONACT- LUPIN |
Available dosage forms | TABLETS |
Dose | Adult- 10 mg daily, increased at 4 weeks interval. Max dose 80 mg. |
Contraindications | 1. Hypersensitivity 2. Active liver diseases or unexplained persistent elevation of serum transaminase 3. Pregnancy 4. lactation |
Precautions | 1. Patients who consume substantial quantities of alcohol and have a history of liver diseases 2. Children below 10 years 3. premenarcheal females 4. Interactions |
Adverse Effects | 1. Myopathy is a serious adverse effect 2. Headache 3. Infrequent elevation of creatinine phosphokinase 4. Rhabdomyolysis 5. Insomnia 6. Dizziness 7. Abdominal pain 8. Constipation 9. Diarrhoea 10. Dyspepsia |
Pregnancy Category | X |
References:
- National formulary
- general information
- Indications
- Indications and dosage
- properties
Pingback: Which are the popular Medicines prescribed for Heart Disorders? - PharmaCampus
Pingback: Pharma Products recall from the US Market > PharmaCampus